Assessing the state of Alzheimer’s imaging

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Posição atual:
>
> This Story

starstarstarstarstar (1)
Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Magazine Features

The road ahead for breast density awareness It's been a good year for advocacy, here's what happens next

OB/GYN ultrasound: is the field ready to adopt new technology in the market? What do new capabilities mean for creatures of habit?

Breast imaging advances with new AI, MR and ultrasound solutions A look at innovative new technology entering the market

Theranostics continue to gain momentum Investments ramp up but challenges remain

In nuclear medicine, scanners get more sensitive, software more specific What's new in PET and SPECT?

See All Magazine Features  

Molecular Imaging Homepage

Bracco Imaging to acquire Blue Earth Diagnostics for $450 million Will gain rights over Axumin

MiE showcases cardiac PET scanner, Ancoris, at SNMMI Provides simultaneous 3D cardiac PET perfusion and CFR

First dual PET isotope scans performed on living organism Discussed at SNMMI 2019 Annual Meeting

Siemens showcases works in progress at SNMMI Includes TeamPlay, syngo Virtual Cockpit and a number of AI algorithms

Philips shares insights on PET/CT utilization trends at SNMMI Continued growth in use expected through 2019

Software innovations for patient-specific theranostics and molecular radiotherapy Trends that will impact the future of medicine

GE debuts Discovery IQ Gen 2 PET/CT system at SNMMI Equipped with MotionFree to prevent blurring of images

Rethinking training and education for the future of medicine at SNMMI Discussing innovations and efforts of SNMMI Technologist Section

Theranostics continue to gain momentum Investments ramp up but challenges remain

SNMMI Product Showcase Don't miss these solutions on the exhibit floor

Assessing the state of Alzheimer’s imaging

por John R. Fischer , Staff Reporter
From the June 2019 issue of DOTmed HealthCare Business News magazine


While a cure may not be available for some time, Minoshima is confident that the research being done today can have a direct and positive impact on the patient outcomes of tomorrow.

“We may not be able to cure Alzheimer’s disease within the next 10 years, but if we better understand the multiple pathways and targets, we may be more effective at intervening in, and slowing down, its progression,” he said.
Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED




For now, researchers continue their efforts to better understand the disease and detect it before it’s already done significant damage.

“If we are able to do a better job of diagnosing Alzheimer’s disease, then hopefully we’ll be able to treat this population early on before full blown dementia takes place,” said Cai. “This is similar to cancer or cardiovascular therapies. The earlier we find the disease, the better the outcome will be.”

Back to HCB News
<< Pages: 1 - 2 - 3 - 4

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment